Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
暂无分享,去创建一个
Jeroen J. Bax | B. Prendergast | A. Unbehaun | J. Webb | B. Whisenant | R. Smalling | S. Redwood | F. Maisano | C. Jung | T. Pilgrim | F. Vincent | L. Nombela‐Franco | H. Wijeysundera | D. Hildick-Smith | S. C. Wong | J. Schofer | R. Makkar | D. Blackman | S. Kar | D. Sugiyama | P. Sorajja | V. Delgado | Won-Keun Kim | H. Sievert | M. Arnold | S. Ensminger | T. Chakravarty | F. D. de Brito | A. Latib | V. Bapat | J. Kempfert | S. Bleiziffer | B. Fujita | Sunghan Yoon | F. Deuschl | T. Schmidt | N. Schofer | S. Kuwata | T. Modine | U. Schaefer | E. Van Belle | G. Tang | D. Murdoch | A. M. Kasel | C. Barker | A. Lauten | J. Masson | H. Treede | Eric J Bansal | J. Davies | E. Gutierrez-Ibanes | A. Frangieh | T. Kaneko | S. Hirji | L. Eschenbach | M. Ancona | Ermela Yzeiraj | M. Asami | A. Dhoble | R. Rampat | M. Silaschi | C. Frerker | G. Attizzani | H. Niikura | C. Jensen | P. Nicz | Sung-Han Yoon | F. S. de Brito | Colin M. Barker | Enrique Gutierrez-Ibanes | S. Yoon | A. Kasel | Abhijeet Dhoble | Sung-Han Yoon
[1] P. Noirhomme,et al. Re-repair of the failed mitral valve: insights into aetiology and surgical management† , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] B. Iung,et al. Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience , 2018, European heart journal.
[3] I. Palacios,et al. 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. , 2018, Journal of the American College of Cardiology.
[4] C. Detter,et al. Hospital Outcome and Risk Indices of Mortality after redo-mitral valve surgery in Potential Candidates for Transcatheter Procedures: Results From a European Registry. , 2017, Journal of cardiothoracic and vascular anesthesia.
[5] W. O’Neill,et al. Short‐term results of alcohol septal ablation as a bail‐out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[6] M. Baiocchi,et al. Mechanical or Biologic Prostheses for Aortic‐Valve and Mitral‐Valve Replacement , 2017, The New England journal of medicine.
[7] Saibal Kar,et al. Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report. , 2017, Journal of the American College of Cardiology.
[8] J. Carroll,et al. 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. , 2017, Journal of the American College of Cardiology.
[9] S. Markwell,et al. Outcomes of Early Mitral Valve Reoperation in the Medicare Population. , 2017, The Annals of thoracic surgery.
[10] R. Hawkins,et al. Contemporary outcomes in reoperative mitral valve surgery , 2017, Heart.
[11] Jeroen J. Bax,et al. Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings. , 2017, Journal of the American College of Cardiology.
[12] W. O’Neill,et al. Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement: First-in-Human Experience. , 2017, JACC. Cardiovascular interventions.
[13] G. Richardt,et al. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes. , 2017, JACC. Cardiovascular interventions.
[14] B. Whisenant,et al. Early Outcomes of Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. , 2017, JACC. Cardiovascular interventions.
[15] Roxana Mehran,et al. Prosthetic Heart Valve Thrombosis. , 2016, Journal of the American College of Cardiology.
[16] B. Whisenant,et al. Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification. , 2016, JACC. Cardiovascular interventions.
[17] Emilia Bagiella,et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. , 2016, The New England journal of medicine.
[18] H. Schaff,et al. Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair: Long-Term Analysis of Competing Outcomes. , 2016, Journal of the American College of Cardiology.
[19] Francois Dagenais,et al. Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. , 2016, The New England journal of medicine.
[20] R. Puri,et al. Transcatheter Valve-in-Valve and Valve-in-Ring for Treating Aortic and Mitral Surgical Prosthetic Dysfunction. , 2015, Journal of the American College of Cardiology.
[21] T. Nazif,et al. Transcatheter Valve Implantation in Failed Surgically Inserted Bioprosthesis: Review and Practical Guide to Echocardiographic Imaging in Valve-in-Valve Procedures. , 2015, JACC. Cardiovascular imaging.
[22] G. Filippatos,et al. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.
[23] R. Lange,et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. , 2014, Journal of the American College of Cardiology.
[24] Antonio Colombo,et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. , 2014, Journal of the American College of Cardiology.
[25] D. Wood,et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. , 2013, Journal of the American College of Cardiology.
[26] S. Chadalavada,et al. A guide to fluoroscopic identification and design of bioprosthetic valves: A reference for valve‐in‐valve procedure , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[27] T. Sundt,et al. Early thrombosis risk in patients with biologic valves in the aortic position. , 2012, The Journal of thoracic and cardiovascular surgery.
[28] J. Lock,et al. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. , 2009, Journal of the American College of Cardiology.
[29] A. Moritz,et al. Midterm survival after decalcification of the mitral annulus. , 2009, Annals of Thoracic Surgery.
[30] Daniel R Wong,et al. Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. , 2009, The Journal of thoracic and cardiovascular surgery.
[31] Lukas Altwegg,et al. Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.
[32] J. Gardin,et al. Burden of valvular heart diseases: a population-based study , 2006, The Lancet.